DifGen Pharmaceuticals and Aveva Drug Delivery Systems today announced a strategic platform collaboration with Biostax Corp d/b/a Attune Biotech, SGP Holdings, and Callan JMB to lead U.S.-based ...

There are various reasons for medication failure,” says Majaha Mtshali, tuberculosis (TB) focal person and staff nurse at Piggs Peak hospital in northwestern Eswatini. “When people do not take their ...

The global pharmaceutical industry will converge in Tashkent, Uzbekistan, from May 20–22, 2026 for Pharma Eurasia 2026, an international exhibition and summit aimed at strengthening pharmaceutical ...

Swiss pharmaceutical giant Novartis said it plans to spend more than CNY3.3 billion (USD460 million) in China, using around ...

Detailed price information for Rakovina Therapeutics Inc (RKV-X) from The Globe and Mail including charting and trades.

Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical ...

The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD. This ...

MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral nutrition (TPN), which is associated with significant toxicities; PS reduction coul ...

Novo Nordisk is facing generics of its GLP-1 drug in India, Atrogi is testing a new weight loss approach, and there's new ...

Cheaper access to semaglutide generics must be matched by strong regulation, education and clinical discipline ...

MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral ...

Rapport Therapeutics, Inc. ( RAPP) Stifel 2026 Virtual CNS Forum March 17, 2026 9:30 AM EDT Great. Good morning, everybody. Happy to be here, moderating this panel with Abe Ceesay, CEO of Rapport ...